Vertex inks $10B Crinetics buy, entering ‘white space blockbuster opportunity’

By /

Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals is the largest pickup in the company’s history, according to analysts at BMO Capital Markets.

Scroll to Top